Metraipolis › archive › dc_57d39c4bb71a

Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access… — Europe PMC PMID:41532708

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41532708
DOI
10.2340/1651-226x.2026.45000
License (as archived)
solo-consultazione
Archived
2026-11-06T20:10:50.754Z
SHA-256 of the archived text
5f6192b10169cef49a7f623fd475ec60e8c2698bea4e6b8140c4862e67fc50e6
Stable URL of this page
https://metraipolis.com/documento/dc_57d39c4bb71a

How to cite

Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access… — Europe PMC PMID:41532708 — Europe PMC (en), https://europepmc.org/article/MED/41532708 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57d39c4bb71a (Metraipolis archive dc_57d39c4bb71a, sha256 5f6192b10169cef49a7f623fd475ec60e8c2698bea4e6b8140c4862e67fc50e6)
BibTeX
@misc{dc57d39c4bb71a,
  title = {Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access… — Europe PMC PMID:41532708},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41532708},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57d39c4bb71a; sha256 5f6192b10169cef49a7f623fd475ec60e8c2698bea4e6b8140c4862e67fc50e6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41532708. Agents can read the archived copy with the MCP tool read_document.